SeQuent Scientific Ltd
NSE:SEQUENT
SeQuent Scientific Ltd
Cash from Operating Activities
SeQuent Scientific Ltd
Cash from Operating Activities Peer Comparison
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
SeQuent Scientific Ltd
NSE:SEQUENT
|
Cash from Operating Activities
₹984.3m
|
CAGR 3-Years
-17%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
|
Cash from Operating Activities
₹72.1B
|
CAGR 3-Years
34%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Cipla Ltd
NSE:CIPLA
|
Cash from Operating Activities
₹37.9B
|
CAGR 3-Years
6%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
|
Cash from Operating Activities
₹121.9B
|
CAGR 3-Years
37%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Zydus Lifesciences Ltd
NSE:ZYDUSLIFE
|
Cash from Operating Activities
₹37.7B
|
CAGR 3-Years
15%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
M
|
Mankind Pharma Ltd
NSE:MANKIND
|
Cash from Operating Activities
₹18.1B
|
CAGR 3-Years
19%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is SeQuent Scientific Ltd's Cash from Operating Activities?
Cash from Operating Activities
984.3m
INR
Based on the financial report for Dec 31, 2023, SeQuent Scientific Ltd's Cash from Operating Activities amounts to 984.3m INR.
What is SeQuent Scientific Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 3Y
-17%
The average annual Cash from Operating Activities growth rates for SeQuent Scientific Ltd have been -17% over the past three years .